Keywords = Combination therapy
Recent advances in molecular targeted therapy of lung cancer: Possible application in translation medicine

Volume 27, Issue 2, February 2024, Pages 122-133

10.22038/ijbms.2023.72407.15749

Elnaz Salmani-Javan; Mahdi Farhoudi Sefidan Jadid; Nosratollah Zarghami


Integration of phytotherapy and chemotherapy: Recent advances in anticancer molecular pathways

Volume 26, Issue 9, September 2023, Pages 987-1000

10.22038/ijbms.2023.69979.15222

Rouhollah Hemmati Bushehri; Parnian Navabi; Amir Mohammad Saeedifar; Nafiseh Keshavarzian; Negin Hosseini Rouzbahani; Ghasem Mosayebi; Ali Ghazavi; Khodayar Ghorban; Ali Ganji


In vivo evaluation of Sono-chemo therapy via hollow gold nanoshells conjugated to mitoxantrone on breast cancer

Volume 26, Issue 3, March 2023, Pages 285-294

10.22038/ijbms.2023.67602.14811

Vahid Abolzadeh; Armin Imanparast; Hooriyeh Nassirli; Naser Tayebi Meybodi; Bahareh Khalili Najafabad; Ameneh Sazgarnia


Combination of metformin and phenformin synergistically inhibits proliferation and hTERT expression in human breast cancer cells

Volume 21, Issue 11, November 2018, Pages 1167-1173

10.22038/ijbms.2018.30460.7345

Davoud Jafari-Gharabaghlou; Younes Pilehvar-Soltanahmadi; Mehdi Dadashpour; Ali Mota; Soheila Vafajouy-Jamshidi; Leila Faramarzi; Sara Rasouli; Nosratollah Zarghami


Cyclooxygenase inhibitors combined with deuterium-enriched water augment cytotoxicity in A549 lung cancer cell line via activation of apoptosis and MAPK pathways

Volume 21, Issue 5, May 2018, Pages 508-516

10.22038/ijbms.2018.25366.6269

Abdolreza Hassanzadeh; Ali Mandegary; Elham Sharif; Rokhsana Rasooli; Reza Mohammadnejad; Yaser Masoumi


PI3K/Akt inhibition and down-regulation of BCRP re-sensitize MCF7 breast cancer cell line to mitoxantrone chemotherapy

Volume 18, Issue 5, May 2015, Pages 472-477

10.22038/ijbms.2015.4410

Tahereh Komeili-Movahhed; Shamileh Fouladdel; Elmira Barzegar; Shekoufeh Atashpour; Mohammad Hossein Ghahremani; Seyed Nasser Ostad; Zahra Madjd; Ebrahim Azizi